Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
3.630
-0.030 (-0.82%)
At close: Apr 25, 2025, 4:00 PM
3.700
+0.070 (1.93%)
After-hours: Apr 25, 2025, 7:54 PM EDT
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $247.33 million as of April 25, 2025. Its market cap has increased by 209.55% in one year.
Market Cap
247.33M
Enterprise Value
196.49M
1-Year Change
209.55%
Ranking
Category
Stock Price
$3.63
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has decreased from $290.80M to $247.33M, a decrease of -14.95%. That is a compound annual growth rate of -1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 249.40M | -27.46% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.39B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |